You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

48 search results for: cytokines

Key Type 2 <b>Cytokines</b> Impact Skin Structural Proteins in Atopic Dermatitis
expert video

Key Type 2 Cytokines Impact Skin Structural Proteins in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about type 2 cytokines and their role in barrier deficiency.
View more
Key Type 2 <b>Cytokines</b> Impact the Skin Microbiome in Atopic Dermatitis
expert video

Key Type 2 Cytokines Impact the Skin Microbiome in Atopic Dermatitis

Type 2 Inflammation
Dr. Stephan Weidinger explains how type 2 cytokines impact the skin microbiome in AD.
View more
Contributions of Type 2 <b>Cytokines</b> to Chronic Pruritus in AD, PN, and CSU
expert video

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU

Dermatology
Dr. Elmariah introduces the multiple roles of type 2 cytokines in chronic itch.
View more
UCARE 2023: Potential Role of Type 2 <b>Cytokines</b> in CSU Pathogenesis
expert video

UCARE 2023: Potential Role of Type 2 Cytokines in CSU Pathogenesis

Dermatology
Dr. Saini summarises the potential role of type 2 cytokines in the pathogensis of CSU.
View more
Contribution of Type 2 <b>Cytokines</b> to Inflammation and Itch in AD, PN, and CSU 
expert video

Contribution of Type 2 Cytokines to Inflammation and Itch in AD, PN, and CSU 

Dermatology
Dr. Marta Ferrer describes the roles of type 2 cytokines in the processes involved in AD, PN, and CSU pathogenesis.
View more
Unique and Overlapping Roles of Type 2 <b>Cytokines</b> in AD and PN
expert video

Unique and Overlapping Roles of Type 2 Cytokines in AD and PN

Dermatology
Explore the unique and shared roles of type 2 cytokines in atopic dermatitis and prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.
View more
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13

Pulmonology
Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.
View more
UCARE 2023: Non-Histaminergic Neuronal Sensitization in CSU
expert video

UCARE 2023: Non-Histaminergic Neuronal Sensitization in CSU

Dermatology
Dr. Kim highlights the role of non-histaminergic neuronal sensitization in CSU via cytokines.
View more
The Impact of Type 2 Inflammation on the Neuroimmune Axis in AD
expert video

The Impact of Type 2 Inflammation on the Neuroimmune Axis in AD

Dermatology
Dr. Gil Yosipovitch discussed the interaction between type 2 inflammation and itch in AD, the role of type 2 inflammation on neuroarchitecture, and the role of type 2 cytokines in neuronal sensitization.
View more
Fisiopatología del prurito
expert video

Fisiopatología del prurito

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more
Emerging Therapeutic Landscape and Implications for Patient Management in PN​
expert video

Emerging Therapeutic Landscape and Implications for Patient Management in PN​

Dermatology
A review of disease burden and treatment needs in PN, and how current and emerging therapies can impact patient management.
View more
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

Pulmonology
Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region